Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study will evaluate the efficacy, safety and effect on quality of life of liposomal-encapsulated doxorubicin in combination with cyclophosphamide as first or second line treatment of older patients (≥ 70 years old) with metastatic breast cancer. The efficacy of the combination will be correlated with the functional status of patients according to the comprehensive geriatric assessment
Critère d'inclusion
- Breast Cancer